Pages

Tuesday, February 25, 2014

InterMune Reports Successful Trial for Lung Disease Drug The company said it would apply for United States regulatory approval of pirfenidone to treat idiopathic pulmonary fibrosis, a scarring of the lungs. ANDREW POLLACK February 26, 2014 at 5:00AM http://nyti.ms/1fo3tMH The New York Times Business Day Drugs (Pharmaceuticals)



By ANDREW POLLACK from NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1fo3tMH

via IFTTT

No comments:

Post a Comment

thank you